Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: Marvel Studios With Marvel’s Phase 5 now complete, its total box office performance, marked by several flop movies, ...

-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58 patients ...

Centessa Pharmaceuticals plc has announced that it will present data from a Phase 1 clinical trial of ORX750, a novel OX2R agonist being developed for narcolepsy type 1, narcolepsy type 2, and ...

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...

Kymera Therapeutics, Inc. (KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral STAT6 protein ...

INmune Bio Inc. has announced the completion of the third and highest dose cohort in the Phase I portion of its clinical trial for the NK cell therapy INKmune™, which is aimed at treating men with ...